期刊文献+

雌激素和大豆异黄酮抗帕金森病的作用及其可能机制

下载PDF
导出
作者 刘黎星
出处 《泰山医学院学报》 CAS 2008年第5期397-400,共4页 Journal of Taishan Medical College
基金 福建省科技厅科研基金项目(2007F5087)
  • 相关文献

参考文献14

  • 1Sawada H,Shimohama S.Estrogens and Parkinson Disease:novel approach for neuroprotection[J].Endocrine,2003,21:77-79.
  • 2Miller DB,Ali SF,O'Callaghan JP,et al.The impact of gender and estrogen on striatal dopamine neurotoxicity[J].Ann NY Acad Sci,1998,(844):153-156.
  • 3Dluzen DE,Disshon KA,Mcdermott JL.Estrogen as a modulator of striatal dopaminergic neurotoxicity[J].In Recent Advances in Neurodegenerative Disorders,1998,149-192.
  • 4Saunders-Pullman R,Gordon-Elliott J,Parides M,et al.The effect of estrogen replacement on early Parkinson's disease[J].Neurology,1999,52(7):1417-21.
  • 5Kuiper GGJM,Carlsson B,Grandien K,et al.Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β[J].Endocrinology,1997,138:863-870.
  • 6Dluzen DE,McDermott JL,Liu B.Estrogen as a neuroprotectant against MPTP induced neurotoxicity in C57BL mice[J].Neurotoxicol Tenatol,1996,18(5):603-605.
  • 7Di Paolo T.Modulation of brain dopamine transmission by sex steoids[J].Rev Neurosci,1994,5:27-42.
  • 8Tina LT,Robert LM.Estrogen regulation of dopamine release in the nucleus accumbens:Genomic-and Nongenomic-Mediated effects[J].Neurochem,1994,62∶1750-1756.
  • 9Liu Y,Fowler CD,Young LJ,et al.Expression and estrogen regulation of brain-derived neurotrophic factor gene and protein in the forebrain of female prairie voles[J].Comp Neurol,2001,433(4):499-514.
  • 10刘黎星,徐丽,陈文芳,谢俊霞,黄文秀.Genistein对帕金森病模型大鼠黑质铁含量及Bcl-2蛋白表达的影响[J].山西医科大学学报,2007,38(5):389-392. 被引量:5

二级参考文献60

  • 1唐小卿,聂亚雄,冯鉴强,陈培熹.姜黄素对H_2O_2损伤PC12细胞的保护作用[J].中国药理学通报,2004,20(6):672-676. 被引量:28
  • 2侯中煜,刘树伟,林祥涛,孟海伟,程葆华,李振平,高波.帕金森病大鼠模型额叶皮质内突触素与神经丝蛋白的表达变化[J].解剖学报,2004,35(6):578-581. 被引量:7
  • 3胡燕,张志军,杨学峰,何志贤,倪衡建.Genistein对体外培养的Parkinson病模型大鼠多巴胺能神经元及突触素的影响[J].神经解剖学杂志,2006,22(3):301-306. 被引量:8
  • 4Maggi A, Perez J. Role of female gonadal hormones in the CNS: clinical and experimental aspect. Life Sci 1985,37:893 -906.
  • 5Braak H, Baak E. Amygdala pathology in Parkinson's disease. Acta Neuropathol 1994,88:493 -500.
  • 6Yoshimoto Y,Sakai K, Luppi PH, Fort P, Salvert D,Jouvet M. Catecholaminergic afferents to the cat median eminence as determined by double-labelling methods.Neuroscience 1990,36(2) :491 -505.
  • 7Peter WK. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev 1993 ,18 :75 - 113.
  • 8Fried I, Wilson CL, Morrow JW, Cameron KA, Behnke ED, Ackerson LC, Maidment NT. Increased dopamine release in the human amygdala during performance of cognitive tasks. Nat Neurosci 2001 ,4(2) :201 -206.
  • 9Thompson TL, Moss RL. Modulation of mesolimbic dopaminergic activity over the rat estrous cycle. Neurosci Lett 1997 ,229 : 145 - 148.
  • 10Arvin M, Fedorkova L, Disshon KA, Dluzen DE, Leipheimer RE. Estrogen modulates responses of striatal dopamine neurons to MPP + : evaluation using in vitro and in vivo techiques. Brain Res 2000,872:160 - 171.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部